Thymosin Alpha-1 for irAE Secondary to ICIs
NCT06178146
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
IrAE
Interventions
DRUG:
Thymosin Alpha1
DRUG:
Immunosuppressant
Sponsor
Jun Wang